Consolidated Statement Of Cash Flows

Fuji Pharma Co.,Ltd. - Filing #7339242

Concept As at
2024-03-31
2023-10-01 to
2024-03-31
As at
2023-09-30
As at
2023-03-31
2022-10-01 to
2023-03-31
As at
2022-09-30
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
149,000,000 JPY
2,116,000,000 JPY
Interest and dividends received
2,000,000 JPY
0 JPY
Interest paid
-81,000,000 JPY
-49,000,000 JPY
Income taxes paid
-516,000,000 JPY
-551,000,000 JPY
Net cash provided by (used in) operating activities
-445,000,000 JPY
1,516,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,884,000,000 JPY
-1,248,000,000 JPY
Proceeds from sale of property, plant and equipment
1,000,000 JPY
5,000,000 JPY
Net cash provided by (used in) investing activities
1,457,000,000 JPY
-2,872,000,000 JPY
Proceeds from sale of investment securities
5,356,000,000 JPY
JPY
Other, net
66,000,000 JPY
JPY
Cash flows from financing activities
Dividends paid
-432,000,000 JPY
-486,000,000 JPY
Proceeds from issuance of bonds
JPY
2,985,000,000 JPY
Repayments of long-term borrowings
-3,810,000,000 JPY
-1,220,000,000 JPY
Redemption of bonds
-300,000,000 JPY
JPY
Net cash provided by (used in) financing activities
-1,998,000,000 JPY
3,058,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
37,000,000 JPY
33,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-948,000,000 JPY
1,735,000,000 JPY
Cash and cash equivalents
1,375,000,000 JPY
2,324,000,000 JPY
5,282,000,000 JPY
3,546,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.